China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK)
Company Info
ISIN | BMG210A71016 |
---|---|
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Highlights
Market Cap | HK$15.55B |
---|---|
PE Ratio | 6.43 |
Year Range | HK$3.01 - HK$5.04 |
Target Price | HK$5.40 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in China Grand Pharmaceutical and Healthcare Holdings Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
China Grand Pharmaceutical and Healthcare Holdings Ltd had a return of 14.49% year-to-date (YTD) and 17.36% in the last 12 months. Over the past 10 years, China Grand Pharmaceutical and Healthcare Holdings Ltd had an annualized return of 12.27%, outperforming the S&P 500 benchmark which had an annualized return of 10.55%.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 14.49% | 13.39% |
1 month | 1.37% | 4.02% |
6 months | 36.12% | 5.56% |
1 year | 17.36% | 21.51% |
5 years (annualized) | 5.03% | 12.69% |
10 years (annualized) | 12.27% | 10.55% |
Monthly Returns
The table below presents the monthly returns of 0512.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -17.60% | 6.53% | 14.48% | 5.60% | 13.60% | -0.53% | -4.09% | -1.12% | 14.49% | ||||
2023 | 6.09% | -8.60% | 1.12% | 13.08% | -0.39% | -10.30% | 0.23% | -8.35% | 3.45% | 0.24% | 5.46% | -7.88% | -8.33% |
2022 | -14.40% | 11.57% | -9.89% | -12.77% | -11.34% | 8.50% | -4.40% | -3.23% | -19.28% | -0.89% | 22.32% | 11.92% | -26.82% |
2021 | -8.72% | -1.27% | -0.48% | 5.67% | 24.08% | -8.99% | -14.88% | 0.32% | 0.16% | 0.64% | 2.24% | 1.09% | -4.78% |
2020 | 16.04% | 0.41% | -6.88% | 11.74% | 3.89% | 3.72% | 34.93% | -3.68% | 0.42% | -11.27% | 7.14% | 1.93% | 65.20% |
2019 | 16.48% | 17.99% | 0.00% | -6.10% | -0.43% | 0.42% | -7.06% | -1.66% | -0.24% | 8.96% | -1.56% | -4.29% | 20.77% |
2018 | 28.35% | 8.79% | -5.64% | 17.33% | 4.92% | -10.68% | -4.37% | 2.86% | -6.11% | -25.05% | 5.26% | -10.50% | -5.53% |
2017 | -1.32% | 11.34% | 14.37% | 10.47% | 3.79% | -6.39% | 2.93% | 26.07% | 1.88% | 5.90% | 9.06% | 21.72% | 150.67% |
2016 | -11.96% | -2.47% | 5.70% | -1.20% | -6.67% | -10.38% | 3.62% | 7.00% | 7.19% | -1.22% | -0.00% | -6.18% | -17.39% |
2015 | -8.44% | -0.70% | 17.14% | 31.10% | 10.69% | -9.24% | -6.02% | -10.84% | 6.08% | 1.04% | -2.57% | -2.65% | 19.49% |
2014 | 77.50% | 2.82% | -4.11% | 1.43% | -3.52% | 8.03% | -0.67% | 8.16% | 0.63% | 10.62% | -6.78% | -6.67% | 92.49% |
2013 | 7.80% | 9.63% | 7.69% | 20.40% | 1.70% | -0.00% | 5.01% | -4.77% | 3.33% | 20.97% | -2.67% | 9.59% | 107.80% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 0512.HK is 58, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
China Grand Pharmaceutical and Healthcare Holdings Ltd granted a 5.86% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.26 per share.
Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Dividend | HK$0.26 | HK$0.14 | HK$0.11 | HK$0.11 | HK$0.10 | HK$0.09 |
Dividend yield | 5.86% | 3.42% | 2.39% | 1.70% | 1.40% | 2.03% |
Monthly Dividends
The table displays the monthly dividend distributions for China Grand Pharmaceutical and Healthcare Holdings Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.26 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.26 | |||
2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.14 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.14 |
2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.11 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.11 |
2021 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.11 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.11 |
2020 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.10 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.10 |
2019 | HK$0.09 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.09 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the China Grand Pharmaceutical and Healthcare Holdings Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the China Grand Pharmaceutical and Healthcare Holdings Ltd was 99.52%, occurring on Sep 5, 2006. The portfolio has not yet recovered.
The current China Grand Pharmaceutical and Healthcare Holdings Ltd drawdown is 62.61%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-99.52% | Mar 6, 1996 | 1905 | Sep 5, 2006 | — | — | — |
-11.64% | Jan 26, 1996 | 10 | Feb 8, 1996 | 14 | Mar 4, 1996 | 24 |
-2.33% | Jan 11, 1996 | 2 | Jan 12, 1996 | 2 | Jan 16, 1996 | 4 |
-0.66% | Jan 19, 1996 | 1 | Jan 19, 1996 | 1 | Jan 22, 1996 | 2 |
Volatility
Volatility Chart
The current China Grand Pharmaceutical and Healthcare Holdings Ltd volatility is 6.79%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of China Grand Pharmaceutical and Healthcare Holdings Ltd compared to its peers in the Drug Manufacturers - Specialty & Generic industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for 0512.HK in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, 0512.HK has a PE value of 6.4. This PE value is considered to be low compared to the rest of the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for 0512.HK in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, 0512.HK has a PEG value of 0.0. This PEG ratio falls in the average range for the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for China Grand Pharmaceutical and Healthcare Holdings Ltd.
Loading data...
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |